Apis Health Angels announces our Final Demo MC.
Apis Health Angel Investors Make their Finalist Selections.
We had an amazing night two of Quarter Finalist companies. 11 founders pitched their ideas in a 3-minute slide show. These are impressive founders all solving important health problems. They wake up and think creatively!
We were thrilled to hear from 13 of our 24 quarter finalists at a 3 minute pitch, 3 minutes of questions, and open mingle for several hours.
Announcing the 12 companies that have made it to our Apis Health Angels Semi Finals! These 12 teams have demonstrated an ability to convince the investors that their ideas are sound, that they have begun to sort out their product customer fit, maybe thought a little about their go-to-market strategies, and speculated on a business model that appears suitable to their solution.
The best way to start early stage investing is to learn by doing. The Apis Health Angel Conference is built for just that.
Our Fall Program included topics in the following areas. Investing: Health Angel Investing is unique with the opportunity for financial returns and societal impact. Maren Nelson talked about being an angel investor and what key things she looks for in an investor pitch. Ky Calder moderated a great panel discussion with Caitlin Cameron, Susan Preston […]
The Apis Health Angel Conference is held semi-annually, with an early year session that runs January to mid-March and a second session still to be determined. During the 11-week program expect 5-10 hours of activity per week including a 2-3 hour Thursday evening session. Each Apis cohort is preceded by a series of optional, virtual workshops hosted on the Innovation in Health Eventbrite page. These workshops provide background on specific topics related to investing and entrepreneurship in health. In addition, the Apis Health Angels investors can join the more general education sessions which are hosted at the Seattle_Angel meetup group. The cost of the program includes two components: A program registration fee of $1000, and an investment of $5000. The program registration fee supports Apis Health Angel program costs, while the investment funds are pooled from all investors and awarded to the winning company via an LLC created for this singular purpose. We are currently reserving slots for Apis Health Angels 2, which starts mid 2022. Each cohort has a limited number of investor slots. These typically fill up fast, so don’t delay. Contact Elizabeth Cross Nichol, Apis Health Angels Program Manager to schedule a call to answer your questions, and provide further details for accredited investors interested in enrolling.
Apis Health Angels benefits from the SAC alumni.
Early stage start up investing requires due diligence on behalf of the investor and the founder.
We are excited to see that there are two health-type startup companies Brainspace Medical and Violett in the finals of SAC 20. These are just the most recent of the health companies that have participated in the Seattle Angel Conference. Other companies have been Abterra Biosciences (SAC19 winner), TENZR (SAC 15 winner), Conquer Experience (SAC IV), Alertive now Carbon Health (SAC XIII winner), Curi-bio (SAC XIII winner). With the increasing interest in the health life sciences sectors more companies are developing solutions and more individuals are wanting to participate in funding these solutions. Our goal is to make a stronger health lifesciences ecosystem focused on more informed investors and more investable startups. We have created Apis Health Angels, a health/life sciences sector-specific angel conference to accomplish this. The program has two components; skill building and investment.I
Understanding the Pitch Process is important for founders and for investors.
We are excited to see the progress that Caitlin Morse and BrainSpace will make with the $200K investment from the SAC 20 Investors.
APIS Health Angels are part of the solution to engage the health ecosystem for funding and development.
APIS Health Angels Launched: Growing Angel Investors + Funding Health Startups.
Michelle has been doing Quality Assurance and Regulatory Affairs for over 20 years. She knows that as a startup founder and an investor you need to know where to put your efforts so that you are focusing on the important stuff. She will take you from 0 to 60 determining a startups' regulatory pathway and first quality system and submission. She also does remediation services for large companies. Serving a four-year term on the FDA Device Good Manufacturing Practices Advisory Committee (DGMP) as an advisor she reviewed feasibility and reasonableness, recommending proposed good manufacturing practice regulations in manufacturing, packing, storing, and installing devices. She was formerly an expert witness in forensic toxicology at the Mississippi Crime Laboratory. Michelle knows how to assess whether a company or an acquisition target’s RAQA issues should scuttle the deal!